If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCroma Security Regulatory News (CSSG)

Share Price Information for Croma Security (CSSG)

Share Price is delayed by 15 minutes
Get Live Data
68.50    0.00 (0.00%)
Bid:
67.00
Ask:
70.00
Spread: 3.00 (4.478%)
Market Cap: £9.43m
CSSG Live PriceLast checked at - London Stock Exchange

Intraday Croma Security Share Chart

Notice of EGM

1 May 2009 14:58

RNS Number : 6119R
Croma Group PLC
01 May 2009
 



Croma Group PLC

Notice of Extraordinary General Meeting 

Croma Group PLC has today posted a circular to shareholders convening an extraordinary general meeting to be held at 5th Floor, 1 Exchange CrescentEdinburgh EH3 8UL at 2.00 p.m. (UK time) on Tuesday, 26 May 2009 at which resolutions in respect of the following will be proposed:

a reduction of the share capital (by cancelling and extinguishing 4.9 pence of the amount paid up or credited as paid up on the issued ordinary shares of 5 pence each in the capital of the Company and reducing the nominal value of each issued and authorised but unissued ordinary share in the capital of the Company to 0.1 pence and by cancelling and extinguishing all of the deferred shares ("Deferred Shares") of 0.5 pence in the share capital of the Company);

a cancellation of the share premium account of the Company;

an alteration to the articles of association reflecting the reductions; and

the grant of new share capital authorities. 

The circular also convenes a class meeting of the holders of Deferred Shares, to be held at 5th Floor, 1 Exchange Crescent, Edinburgh EH3 8UL at 2.20 p.m. (UK time)(or as soon thereafter as the extraordinary general meeting of the Company to be convened for 2.00 p.m. on the same day and at the same place shall have concluded or been adjourned) on Tuesday, 26 May 2009, at which a resolution to cancel and extinguish each of the Deferred Shares will be proposed.

The proposed share capital and share premium account reductions (which require both shareholder and High Court approval) have two principal purposes. The first is to eliminate the deficit on the Company's profit and loss account in order to give the Company greater flexibility in the future to begin to pay dividends and to manage its capital base. The second is to address another significant issue facing the Company. The nominal value of an ordinary share in the share capital of the Company is 5 pence. The average mid-market price of an ordinary share in the share capital of the Company over the 30 dealing days prior to 30 April 2009 (being the latest practicable date prior to the publication of this document) was approximately 1.52 pence. A company is prohibited by law from issuing shares at a discount to their nominal value. Accordingly, for practical purposes, the Company is not presently able to raise further finance by means of an issue of ordinary shares. If approved, the share capital reduction would result in the nominal value of an Ordinary Share being reduced to 0.1 pence, which would address this issue. 

Subject to shareholder and High Court approval being obtained, it is hoped that the reductions will take effect prior to the end of June 2009.

A copy of the circular is available for download from the investor relations section of the Company's website at www.cromagroup.co.uk

Enquiries:

Croma Group PLC

Sebastian Morley, CEO Tel: 07768 006909

Seymour Pierce Limited

Mark Percy/Catherine Leftley Tel: 020 7107 8000


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NOEUUUQAAUPBGWG
Date   Source Headline
1st Jul 20267:00 amRNSReceived Final Payment from Vigilant Disposal
16th Mar 20267:00 amRNSAcquisition
16th Mar 20267:00 amRNSAcquisition
26th Feb 20267:00 amRNSHalf-year Financial Report
23rd Feb 20264:58 pmRNSHolding(s) in Company
3rd Feb 20267:00 amRNSNotice of Results
15th Jan 20268:32 amRNSDirector Dealing
5th Jan 20267:00 amRNSAcquisition
1st Dec 202511:30 amRNSResult of AGM
25th Nov 20257:00 amRNSNotice of AGM
3rd Nov 20257:00 amRNSFinal Results
30th Oct 20257:00 amRNSNotice of Results and Investor Presentation
23rd Oct 20257:00 amRNSDirectorate Change
5th Sep 20251:59 pmRNSBoard Change
2nd Sep 20253:29 pmRNSBoard Change
16th Jul 202511:19 amRNSHolding(s) in Company
9th Jul 20257:00 amRNSTrading Statement
8th May 20253:55 pmRNSDirector/PCA Dealings
25th Apr 20256:10 pmRNSDirector/PDMR Shareholding
1st Apr 20257:00 amRNSAcquisition
6th Mar 20257:00 amRNSGrant of Options
24th Feb 20257:00 amRNSHalf-year Report
19th Feb 20257:00 amRNSNotice of Results and Investor Presentations
3rd Feb 20257:00 amRNSAcquisition
20th Jan 20257:00 amRNSTrading Statement
4th Dec 20249:26 amRNSResult of AGM
4th Dec 20247:00 amRNSAGM Statement
28th Nov 20247:00 amRNSNotice of AGM
5th Nov 202411:10 amRNSDirector Dealing
5th Nov 20247:00 amRNSNotice of Investor Presentation
4th Nov 20247:00 amRNSFinal Results
29th Oct 20242:38 pmRNSDirector/PCA Dealings
14th Aug 20247:00 amRNSHolding(s) in Company
22nd Jul 20247:00 amRNSTrading Statement
15th Jul 20247:00 amRNSChange of Adviser
8th Jul 20247:00 amRNSReceipt of Deferred Consideration
3rd Apr 20247:00 amRNSNHS Contract Win
21st Feb 20247:00 amRNSHalf-year Report
29th Jan 20247:00 amRNSTrading Statement
8th Jan 20247:00 amRNSAcquisition
1st Dec 202310:24 amRNSResult of AGM
16th Nov 20237:00 amRNSNotice of AGM
13th Nov 202312:54 pmRNSDirector Dealing
13th Nov 20237:00 amRNSGrant of Options
8th Nov 20237:00 amRNSNotice of Investor Presentation
7th Nov 20237:00 amRNSFinal Results
26th Oct 20232:42 pmRNSTransaction in own shares and total voting rights
26th Oct 20237:00 amRNSTransaction in own shares and total voting rights
8th Aug 202310:17 amRNSHolding(s) in Company
7th Aug 202311:10 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.